logo
  

Hikma Pharma Launches Outsourced Sterile Compounding Business - Quick Facts

Hikma Pharmaceuticals PLC (HIK,HIK.L) has launched Hikma 503B, a new outsourced sterile compounding business focused on providing ready-to-administer injectable medications that are customized to the specific needs of patients in the U.S. Hikma 503B is expected to be operating nationwide by the end of 2022. It will operate principally out of a purpose-built facility in Dayton, NJ.

"Hikma 503B is a natural extension of our injectables business, building on our strong relationships with US hospitals and excellent quality manufacturing protocols to provide urgently needed product offerings to patients and health care providers in the US," said Riad Mishlawi, President, Injectables, Hikma.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Richmond, Utah-based Casper's Ice Cream is recalling its 56 ounce tubs of "Red Button Vintage Creamery Canadian Vanilla Ice Cream" due to undeclared allergen, the U.S. Food and Drug Administration said. According to the agency, a limited number of the product were mispackaged with Burnt Almond Fudge Ice Cream containing undeclared almonds. Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement. The U.S. Food and Drug Administration said it has taken steps to make available millions of cans of additional infant and specialty formula to U.S. consumers in the coming months. Under the agency's recent increased flexibilities, British nutrition products maker Kendal Nutricare will send about 2 million cans of infant formula under the Kendamil brand initially to U.S. beginning in June.
Follow RTT